The eyonis™ Lung Cancer Screening (LCS) REALITY data – What leading U.S. clinical pulmonology experts are saying

November 7, 2024

We invite you to join this KOL webinar featuring two globally recognized U.S. pulmonology experts to get their views on the data from REALITY and how eyonis™ LCS may impact lung cancer diagnostics and treatment practices in the real world. Panelists include Prof. Anil Vachani, from the Hospital of the University of Pennsylvania, and Prof. Javier Zulueta, from the Icahn School of Medicine at Mt Sinai. Fredrik Brag, CEO of Median Technologies, also will participate and summarize the final REALITY results, which are going to be submitted in H1 2025 to regulators for U.S. and EU marketing authorizations for eyonis™ LCS.

Register To Our Live Webcast

Median Technologies: Imaging in Clinical Trials

At Median we’re determined to push the boundaries of what Imaging Technology can achieve, to help develop next-generation treatments with the potential to save or improve the lives of millions. We’re already transforming the use of medical images in Clinical Trials and patient care; extracting the highest quality, most advanced Imaging Biomarkers to set the standard for developing new therapies, diagnosing disease and treating patients. We’re helping biopharmaceutical organizations around the world make quicker, better-informed decisions, bringing new therapies closer every day.

WATCH: Median Technologies: Imaging in Clinical Trials